Birth outcomes following antiretroviral exposure during pregnancy: Initial results from a pregnancy exposure registry in South Africa

Southern African Journal of HIV Medicine

Ushma C. Mehta¹  Karen Fieggen²  Michael F. Urban³  Otty Mhlongo⁴  Neil F. Moran⁴  Prineetha Naidoo⁵  Arthi Ramkissoon⁵  Yogan Pillay⁶  Niree Naidoo⁷  Niren R. Maharaj⁷  Mukesh Dheda⁸  Cari van Schalkwyk⁹  Alex Welte⁹  Shaun Krog^1,10 

[1] Centre for Infectious Disease Epidemiology and Research (CIDER), School of Public Health and Family Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town;Division of Human Genetics, Department of Medicine, University of Cape Town, Cape Town;Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town;KwaZulu-Natal Department of Health, Pietermaritzburg;Maternal and Adolescent Child Health Systems (MatCH), School of Public Health, University of the Witwatersrand, Johannesburg;National Department of Health, Pretoria;Prince Mshiyeni Memorial Hospital, Durban;Programmatic Pharmacovigilance Unit, National Department of Health, Pretoria;South African Centre for Epidemiological Modelling and Analysis, Stellenbosch;VP Health Systems, KwaZulu-Natal, Durban;

关键词: pharmacovigilance;    antiretrovirals;    pregnancy;    birth outcomes;    safety;    birth defect;    congenital malformations;    surveillance;   

DOI  :  10.4102/sajhivmed.v20i1.971

来源: DOAJ

【 授权许可】

Unknown